Last April I wrote about the FDA’s decision to ban the use of surgical mesh devices for transvaginal repair of pelvic organ prolapse (“transvaginal mesh” or “pelvic mesh”). https://www.videntpartners.com/blog/2019/fda-bans-surgical-mesh-transvaginal-repair-pelvic-organ-prolapse. Of course, because transvaginal mesh was used for that purpose for 14 years (2002-2016), the resulting litigation isn’t over yet. The most recent case to come to my attention is Kaiser v.
The FDA’s announcement of the ban is at https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm:
